Table 4.
Numbers of boys aged 12 who would need to be vaccinated (95% credible interval) per outcome prevented in relation to HPV 16/18 vaccine uptake in men*
| Outcome prevented | Projected vaccine coverage in boys | ||
|---|---|---|---|
| 30% | 50% | 70% | |
| At 60% vaccine coverage in girls† | |||
| Any cancer | 609 (495 to 761) | 639 (527 to 788) | 676 (563 to 827) |
| QALY lost | 86 (68 to 110) | 91 (72 to 115) | 94 (76 to 119) |
| At 90% vaccine coverage in girls† | |||
| Any cancer | 1401 (1016 to 2223) | 1483 (1085 to 2388) | 1611 (1160 to 2602) |
| QALY lost | 176 (127 to 281) | 181 (130 to 295) | 192 (137 to 314) |
QALY=quality adjusted life year.
*Assuming similar efficacy against cancers as against high grade cervical intraepithelial neoplasia.
†Three dose uptake among girls aged 12: 60% is current level and 90% is target level.